Record-Breaking Price Movement
On 12 August 2026, Vaxfab Enterprises Ltd’s share price closed at ₹68.00, matching its 52-week high and setting a new all-time peak. The stock recorded an intraday high of ₹67.93, representing a daily gain of 4.57%, and outperformed the sector by 2.45%. This positive momentum followed a two-day recovery after consecutive declines, signalling renewed investor confidence in the stock’s trajectory.
The day’s performance was particularly notable against the Sensex, which declined by 0.41%, while Vaxfab Enterprises Ltd surged by 4.68%. Over the past week, the stock gained 6.10%, contrasting with the Sensex’s 0.95% fall. The one-month return stood at 13.33%, significantly ahead of the Sensex’s modest 0.34% rise. Over three months, the stock’s appreciation of 38.21% dwarfed the Sensex’s 4.39% gain.
Long-Term Outperformance
Vaxfab Enterprises Ltd’s long-term performance has been exceptional. The stock has delivered a staggering 272.40% return over the past year, while the Sensex declined by 2.99% during the same period. Year-to-date, the company’s shares have risen by 80.71%, in stark contrast to the Sensex’s 8.67% fall. Over three years, the stock has appreciated by 237.30%, compared to the Sensex’s 19.15% gain, and over five years, the return has been an extraordinary 784.27%, far exceeding the Sensex’s 41.92% increase.
These figures underscore the stock’s ability to generate substantial value for shareholders over extended periods, despite operating within the micro-cap segment of the trading and distributors sector.
Technical Indicators Signal Bullish Momentum
The technical outlook for Vaxfab Enterprises Ltd remains strongly bullish. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained upward momentum. The overall technical trend shifted to bullish on 16 April 2026 at a price of ₹44.18, marking a clear trend reversal from a previously mildly bullish stance.
Key technical indicators such as the MACD and KST are bullish on both weekly and monthly timeframes, while Bollinger Bands suggest mild to full bullishness. The Relative Strength Index (RSI) shows a bearish signal on the weekly chart but no clear signal monthly, reflecting some short-term consolidation amid the broader uptrend. Immediate support is established at the 52-week low of ₹17.03, with major resistance levels previously encountered at ₹47.33 (200-day moving average) and ₹54.22 (100-day moving average) now decisively surpassed.
Valuation Metrics Reflect Elevated Multiples
At the current price of ₹68.00, Vaxfab Enterprises Ltd trades at a price-to-earnings (P/E) ratio of 144 times trailing twelve months earnings, indicating a premium valuation relative to typical market standards. The price-to-book value stands at 3.79 times, while the enterprise value to sales ratio is 1.58 times. Negative enterprise value to EBITDA and EBIT multiples (-42.77x and -24.30x respectively) reflect recent earnings volatility and losses at the operating level.
Dividend metrics are not applicable as the company has not declared dividends recently, and no dividend yield is reported. The valuation assessment remains incomplete due to limited data availability, but the elevated multiples suggest that the market is pricing in strong growth expectations despite some underlying financial challenges.
Financial and Quality Assessment Highlights
Vaxfab Enterprises Ltd’s financial trends present a mixed picture. The company reported higher net sales of ₹79.53 crores and a profit after tax (PAT) of ₹1.00 crore for the nine-month period ending March 2026. The quarterly earnings per share (EPS) reached a peak of ₹3.60. However, the latest six-month figures show a decline in net sales by 48.98% to ₹24.49 crores and a 60.51% drop in PAT to ₹3.25 crores. Quarterly profit before depreciation, interest, and tax (PBDIT) and profit before tax (PBT) less other income were at their lowest levels, indicating some recent operational pressures.
The company’s debtors turnover ratio for the half-year was 0.88 times, reflecting slower collections. Non-operating income accounted for 136.73% of profit before tax in the quarter, highlighting reliance on non-core income sources. Despite these challenges, the company maintains a moderate leverage profile with an average net debt to equity ratio of 0.95 and negative net debt overall.
Quality Metrics and Growth Trends
Quality assessments classify Vaxfab Enterprises Ltd as a below-average quality company based on long-term financial performance. Management risk, growth, and capital structure are all rated below average. The company has demonstrated healthy long-term sales growth, with a five-year compound annual growth rate (CAGR) of 87.60%. However, earnings before interest and tax (EBIT) growth over five years has been negative at -845.00%, and average return on capital employed (ROCE) and return on equity (ROE) remain weak at -9.99% and 1.78% respectively.
On a positive note, the company has no promoter share pledging and low institutional holdings at 0.04%, indicating stable ownership. The average sales to capital employed ratio is 1.49 times, and the tax ratio stands at 48.40%, reflecting the company’s tax obligations.
Delivery Volumes Indicate Increased Market Activity
Recent delivery volumes have shown a marked increase, with a 92.9% rise over the past month and an 86.01% increase on the latest trading day compared to the five-day average. On 11 August 2026, delivery volume accounted for 58.81% of total volume, significantly higher than the trailing one-month average of 46.43% and the previous month’s 70.42%. This heightened activity suggests growing market participation in the stock as it reached its all-time high.
Summary of Market Capitalisation and Ratings
Vaxfab Enterprises Ltd is classified as a micro-cap company within the trading and distributors sector. The MarketsMOJO Mojo Score stands at 31.0, with a current Mojo Grade of Sell, downgraded from Hold on 26 May 2026. This rating reflects a cautious stance based on the company’s financial and quality metrics despite the recent price appreciation.
Conclusion
Vaxfab Enterprises Ltd’s stock reaching an all-time high of ₹68.00 on 12 August 2026 marks a significant milestone in its market journey. The stock’s strong performance across multiple time horizons, supported by bullish technical indicators and increased market activity, highlights its resilience and capacity for value creation. While valuation multiples remain elevated and some financial metrics indicate areas for improvement, the company’s long-term sales growth and absence of promoter pledging provide a foundation for its current market standing. This achievement underscores the dynamic nature of micro-cap stocks within the trading and distributors sector and reflects the evolving market sentiment surrounding Vaxfab Enterprises Ltd.
